In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
Analysis of Overall Survival secondary endpoint of the full population indicates that seribantumab decreased risk of death by more than 50% in HER2-negative, hormone receptor positive breast cancer patients